Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Sulzer Ltd
  6. News
  7. Summary
    SUN   CH0038388911


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sulzer : shareholders approve demerger plan and incorporation of medmix AG and all other proposals at Extraordinary General Meeting

09/20/2021 | 01:22am EDT

Sulzer's shareholders approved all proposals of Sulzer board of directors at the EGM held in Winterthur, Switzerland, on September 20, 2021. Due to the pandemic and in line with the COVID-19 Ordinance 3 of the Swiss Federal Council, shareholders did not attend the EGM in person. They were advised to authorize and instruct the independent proxy to cast their votes on their behalf. The independent proxy represented 79.13% of the share capital.

The Sulzer shareholders approved the demerger plan (a qualified majority of two thirds of the represented votes was required) and the incorporation of medmix, with a majority of more than 99.56%.

Grégoire Poux-Guillaume was elected as member and chairman of the board of directors of medmix, along with Jill Lee Ghim Ha and Marco Musetti who were elected as members of the board of directors, all of them for a one-year term. Grégoire Poux-Guillaume, Jill Lee Ghim Ha and Marco Musetti were also elected to serve on medmix' remuneration committee.

The Sulzer shareholders further approved the election of KPMG AG, Zurich, as auditors for medmix, and the election of Proxy Voting Services GmbH, Zurich, as the independent proxy for medmix. Finally, the shareholders approved the maximum aggregate compensation for the board of directions of medmix for the coming term of office, as well as the maximum aggregate compensation for the executive committee for the remainder of the financial year 2021 and for the financial year 2022.

The applications to the commercial register authorities in Zurich and Zug to register and, hence, formally effectuate the demerger and the incorporation of medmix will be filed today.

After the EGM, the newly elected board of directors of medmix held the first board meeting dealing, among other things, with the self-constitution of the medmix board. The medmix board members appointed Marco Musetti as vice-chairman. Jill Lee Ghim Ha will chair medmix' audit committee and Marco Musetti will chair the remuneration committee. The board of directors of medmix reiterated its intention to propose at least two additional independent members for election at the AGM in spring 2022.

We wish Girts Cimermans, leaving the executive committee of Sulzer AG due to the demerger and his team a lot of success at medmix.

As already announced in our press release dated September 6, 2021, the expected timetable for the listing of the medmix shares and the capital increase of medmix is the following:


Sulzer AG published this content on 20 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 September 2021 05:21:00 UTC.

© Publicnow 2021
All news about SULZER LTD
10/13SULZER : supporting award-winning water treatment plant to irrigate 70'000 acres of agricu..
10/13SULZER : 13.10.21 Media release Supporting award-winning water treatment plant
10/07SULZER : Stifel Lowers Price Target on Sulzer, Upgrades Recommendation to Buy From Hold
10/06SULZER : 06.10.21 Developing pumps for higher temperature systems
10/04SULZER : Bank Vontobel Lowers Price Target on Sulzer AG, Downgrades Recommendation to Hold
10/01ANALYST RECOMMENDATIONS : Acceleron Pharma, General Mills, Southwest Airlines, Home Depot,..
10/01SULZER : Morgan Stanley Lowers Price Target on Sulzer, Maintains Equalweight/Cautious Reco..
09/30GLOBAL MARKETS LIVE : Boeing, Walgreens, Dufry, M&S, Novartis...
09/30SULZER : Spinoff Debuts On Swiss Bourse, Raises $338 Million Capital
09/30SULZER : and medmix shares start trading separately on SIX Swiss Exchange – medmix a..
More news
Analyst Recommendations on SULZER LTD
More recommendations
Sales 2021 3 219 M 3 512 M 3 512 M
Net income 2021 144 M 158 M 158 M
Net Debt 2021 477 M 521 M 521 M
P/E ratio 2021 20,2x
Yield 2021 3,63%
Capitalization 3 078 M 3 358 M 3 359 M
EV / Sales 2021 1,10x
EV / Sales 2022 1,03x
Nbr of Employees 15 574
Free-Float 49,4%
Duration : Period :
Sulzer Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SULZER LTD
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 5
Last Close Price 91,10 CHF
Average target price 105,00 CHF
Spread / Average Target 15,3%
EPS Revisions
Managers and Directors
Grégoire Poux-Guillaume Chief Executive Officer
Jill Ghim Ha Lee Chief Financial Officer
Peter D. Löscher Chairman
Gerhard Roiss Independent Non-Executive Director
Hanne Birgitte Sorensen Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
SULZER LTD46.12%3 358
ATLAS COPCO AB32.42%75 542
SANDVIK AB11.67%32 868